Safety and Efficacy of Low-intensity Laser Therapy in the Treatment of Chronic Musculoskeletal Pain
Unknown statusNot applicableNCT06009900
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study is a multicenter, prospective, randomized, controlled research design. This study takes classic NSAIDs treatment as a control, and it will take patients' pain relief, functional improvement, sleep quality improvement, and adverse reactions as the main and secondary evaluation indicators to explore the safety and effectiveness of weak laser treatment of chronic musculoskeletal pain, determining the dominant disease in the treatment of Chronic pain.
Study details
- Official title
- Safety and Efficacy of Low-intensity Laser Therapy in the Treatment of Chronic Musculoskeletal Pain: a Multicenter Randomized Controlled Trail
- Conditions
- Interventions
- Device: Low intensity laser treatment
- Drug: Non-steroidal drug (Celecoxib) group
- Sponsor
- Tongji Hospital
- Collaborators
- Shanxi Bethune Hospital; Second Hospital of Shanxi Medical University; Shanxi Provincial People's Hospital; China Resources WISCO General Hospital; Linfen No.4 People's Hospital
- Start date
- 2023-09-01
- Primary completion
- 2023-09-01
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- China
- Total sites listed
- 5
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Age ≥ 18 years old; 2. Chronic musculoskeletal pain (including cervical spondylosis, periarthritis of shoulder, osteoarthritis, back muscle Fasciitis, lumbar disc herniation) was diagnosed, and the pain lasted for more than 3 months; 3. The degree of pain before treatment was mild to moderate (NRS score\<7 points); 4. Can cooperate in completing consultation and scale evaluation; 5. Sign an informed consent form. Exclusion Criteria: 1. Previous spinal surgery or severe spinal diseases (such as fractures, tumors, inflammation, and infectious diseases); 2. Suffering from serious systemic diseases, including liver and kidney dysfunction, cardio cerebral, vascular disease, decompensated metabolic syndrome; 3. Serious skin diseases (skin cancer, erysipelas, severe eczema, severe dermatitis, severe psoriasis, lupus, Hives); 4. Suffering from mental disorders, intellectual disabilities, epilepsy and other diseases; 5. Moderate to severe depressive state; 6. Have a history of drug abuse, drug abuse, and alcohol abuse; 7. Individuals with contraindications to NSAIDs or laser therapy; 8. Pregnant women; 9. Recently participated in other clinical studies.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06009900